Live Breaking News & Updates on Chengdu Small Molecule Early Rd Center

Stay updated with breaking news from Chengdu small molecule early rd center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) combined with R-CHOP for the treatment of diffuse large B-cell lymphoma

/PRNewswire/ Shenzhen Chipscreen Biosciences Co., Ltd. (Chipscreen Biosciences, Stock Symbol: 688321.SH) announced that the company s lead innovative. ....

Feng Wang , United States , Ruihua Xu , Sun Yat , Xianping Lu , Chidamide Tucidinostat , Chipscreen Biosciences , Weili Zhao , Chidamide Epidaza , Data Monitoring Committee , Chipscreen Biosciences United States Co Ltd , Prnewswire Shenzhen Chipscreen Biosciences Co Ltd , Chengdu Small Molecule Early Rd Center , Shanghai Jiao Tong University School Of Medicine , Chengdu Regional Head Office Rd Center , Shenzhen Chipscreen Biosciences Co Ltd , Shenzhen Small Molecule Early Rd Center , Innovative Drug Development , Shenzhen Head Office Rd Center , National Science , Treatment Center , National Medical Products Administration , American Society Of Clinical Oncology , Shanghai Branch , Stock Symbol , Independent Data Monitoring Committee ,